amifostine anhydrous has been researched along with ditiocarb in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 10 (66.67) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fichtinger-Schepman, AM; Nijtmans, LG; Treskes, M; van der Vijgh, WJ | 1 |
| Holwerda, U; Nijtmans, LG; Pinedo, HM; Treskes, M; van der Vijgh, WJ | 1 |
| Luginbuhl, WE; Meropol, NJ; Schuchter, LM | 1 |
| Cvitkovic, E; Golbey, RB; Hayes, DM; Krakoff, IH | 1 |
| De Gregorio, MW; Gandara, DR; Perez, EA; Weibe, V | 1 |
| Carfagna, PF; Chaney, SG; Chang, J; Holbrook, DJ | 1 |
| Tognella, S | 1 |
| DeGregorio, MW; Gandara, DR; Makuch, RW; Perez, EA; Wiebe, VJ | 1 |
| Leyland-Jones, B | 1 |
| Brock, WA; Meyn, RE; Milas, L; Murray, D | 1 |
| Davis, HD; Dominitz, JA; Landauer, MR; Weiss, JF | 1 |
| Blakley, BW; Burgio, DL; Church, MW; Kaltenbach, JA | 1 |
| Blakley, BW; Burgio, DL; Church, MW; Kaltenbach, JA; McCaslin, DL | 1 |
| Albers, J; Cavaletti, G; Chaudhry, V; Donehower, R | 1 |
| Brock, P; Cabral, S; Freyer, DR; Knight, K; Reaman, G; Robinson, PD; Sung, L | 1 |
7 review(s) available for amifostine anhydrous and ditiocarb
| Article | Year |
|---|---|
The current status of toxicity protectants in cancer therapy.
Topics: Amifostine; Antineoplastic Agents; Clinical Trials as Topic; Cytokines; Ditiocarb; Drug Evaluation, Preclinical; Humans; Male; Neoplasms; Radiation-Protective Agents | 1992 |
Cisplatin chemoprotection and rescue: pharmacologic modulation of toxicity.
Topics: Adrenocorticotropic Hormone; Amifostine; Anticonvulsants; Cisplatin; Ditiocarb; Humans; Inactivation, Metabolic; Kidney Diseases; Neoplasms; Peptide Fragments | 1991 |
Pharmacological interventions to reduce platinum-induced toxicity.
Topics: Adrenocorticotropic Hormone; Amifostine; Cisplatin; Ditiocarb; Fluid Therapy; Glutathione; Hematologic Diseases; Humans; Kidney Diseases; Nervous System Diseases; Peptide Fragments; Thiosulfates | 1990 |
Cisplatin rescue therapy: experience with sodium thiosulfate, WR2721, and diethyldithiocarbamate.
Topics: Amifostine; Antidotes; Cisplatin; Ditiocarb; Drug Therapy, Combination; Humans; Kidney Diseases; Thiosulfates | 1990 |
Radioprotectors in tumor radiotherapy: factors and settings determining therapeutic ratio.
Topics: Amifostine; Animals; Cells, Cultured; Ditiocarb; Humans; Immune Tolerance; Neoplasm Metastasis; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Radiation Injuries, Experimental; Radiation-Protective Agents | 1988 |
Interventions for preventing neuropathy caused by cisplatin and related compounds.
Topics: Adrenocorticotropic Hormone; Amifostine; Antineoplastic Agents; Cisplatin; Ditiocarb; Glutathione; Humans; Neuroprotective Agents; Peptide Fragments; Peripheral Nervous System Diseases; Randomized Controlled Trials as Topic; Vitamin E | 2007 |
Interventions for cisplatin-induced hearing loss in children and adolescents with cancer.
Topics: Acetylcysteine; Adolescent; Amifostine; Anti-Inflammatory Agents; Antineoplastic Agents; Chelating Agents; Child; Cisplatin; Cytoprotection; Dexamethasone; Disulfiram; Ditiocarb; Humans; Neoplasms; Ototoxicity; Thiosulfates | 2019 |
8 other study(ies) available for amifostine anhydrous and ditiocarb
| Article | Year |
|---|---|
Effects of the modulating agent WR2721 and its main metabolites on the formation and stability of cisplatin-DNA adducts in vitro in comparison to the effects of thiosulphate and diethyldithiocarbamate.
Topics: Amifostine; Animals; Buffers; Cisplatin; Ditiocarb; DNA; DNA Adducts; Hydrogen-Ion Concentration; Mercaptoethylamines; Salmon; Thiosulfates | 1992 |
The reversal of cisplatin-protein interactions by the modulating agent WR2721 and its metabolites WR1065 and WR33278.
Topics: Amifostine; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Cisplatin; Ditiocarb; Drug Interactions; Drug Stability; Fumarate Hydratase; Glutathione; Kinetics; Mercaptoethylamines; Radiation-Protective Agents; Spectrophotometry, Ultraviolet | 1992 |
Cisplatin nephrotoxicity: diethyldithiocarbamate, WR2721, or just water?
Topics: Acute Kidney Injury; Amifostine; Cisplatin; Ditiocarb; Fluid Therapy; Humans | 1991 |
Reduction of tetrachloro(dl-trans)1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) toxicity by the administration of diethyldithiocarbamate (DDTC), S-2(3-aminopropylamino)ethylphosphorothioic acid (WR-2721), or sodium selenite in the Fischer 344 rat.
Topics: Amifostine; Animals; Antineoplastic Agents; Antiviral Agents; Blood Urea Nitrogen; Creatinine; Ditiocarb; Gastrointestinal Diseases; Intestine, Large; Intestine, Small; Kidney Diseases; Leukocyte Count; Male; Organoplatinum Compounds; Organothiophosphorus Compounds; Rats; Rats, Inbred F344; Selenium; Sodium Selenite; Spleen; Thymus Gland | 1990 |
Whither the modulation of platinum?
Topics: Amifostine; Antimetabolites; Buthionine Sulfoximine; Cisplatin; Ditiocarb; Humans; Methionine Sulfoximine | 1988 |
Comparative behavioral toxicity of four sulfhydryl radioprotective compounds in mice: WR-2721, cysteamine, diethyldithiocarbamate, and N-acetylcysteine.
Topics: Acetylcysteine; Amifostine; Animals; Cysteamine; Ditiocarb; Drug Evaluation, Preclinical; Male; Mice; Mice, Inbred BALB C; Motor Activity; Radiation-Protective Agents; Sulfhydryl Compounds | 1988 |
The comparative effects of sodium thiosulfate, diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity.
Topics: Amifostine; Animals; Anti-Bacterial Agents; Antidotes; Antineoplastic Agents; Auditory Threshold; Cisplatin; Cochlea; Cricetinae; Ditiocarb; Drug Interactions; Electrophysiology; Evoked Potentials, Auditory, Brain Stem; Fosfomycin; Hair Cells, Auditory; Hearing Loss, Sensorineural; Injections, Intraperitoneal; Male; Mesocricetus; Microscopy, Electron, Scanning; Radiation-Protective Agents; Random Allocation; Thiosulfates | 1995 |
Comparison of five agents in protecting the cochlea against the ototoxic effects of cisplatin in the hamster.
Topics: Amifostine; Animals; Antidotes; Antineoplastic Agents; Antioxidants; Auditory Threshold; Cell Survival; Chelating Agents; Cisplatin; Cochlea; Cricetinae; Ditiocarb; Drug Combinations; Evoked Potentials, Auditory, Brain Stem; Fosfomycin; Hair Cells, Auditory, Inner; Hair Cells, Auditory, Outer; Mesocricetus; Microscopy, Electron, Scanning; Organ of Corti; Semicircular Canals; Thiosulfates | 1997 |